Thomas Andreas Forst

Professor Thomas Andreas Forst is a board-certified physician in Internal Medicine and Endocrinology with a distinguished clinical, academic, and research career focused on diabetes, obesity, and metabolic disorders. He began his postdoctoral clinical and scientific career in 1989 at the German Diabetes Research Institute (Leibniz Institute) at Heinrich Heine University Düsseldorf. In 1991, he joined the Department of Internal Medicine at Johannes Gutenberg University Mainz, where he completed his specialist training in Internal Medicine in 1996 and Endocrinology in 1997. He was appointed Professor of Internal Medicine at Johannes Gutenberg University Mainz in 2006 and continues to contribute to medical education and the training of medical students.

From 1999 to 2001, Professor Forst served as a Clinical Research Physician at Eli Lilly, where he supervised multiple clinical trials in diabetes and related comorbidities. In 2001, he was appointed Chief Executive Officer and Medical Director of the Institute for Clinical Research and Development in Mainz. In 2013, he joined Profil Institute Mainz as Chief Executive Officer and Director of Medical Science. Since 2018, he has served as Chief Medical Officer at Clinical Research Services Germany. Throughout his career, he has participated in more than 300 clinical trials in the fields of obesity, metabolic diseases, diabetes, dyslipidemia, and cardiovascular disease.

Professor Forst is an active member of the American Diabetes Association, the European Association for the Study of Diabetes, and the German Diabetes Association (DDG). He currently serves as Chair of the DDG Working Group “Diabetes and Heart” and as a board member of the DDG Neuropathy Study Group. He has authored or co-authored more than 300 peer-reviewed scientific publications in national and international journals and is widely recognized for his contributions to clinical diabetes research and translational medicine.